Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
Sponsor: Daewoong Pharmaceutical Co. LTD.
Summary
This study is a prospective, multi-center, observational study to evaluate the efficacy and safety of Fexuclue Tablet 20 mg in patients requiring prevention of NSAIDs-induced peptic ulcer in real-world clinical practice in Korea. Patients receiving NSAIDs and requiring gastroprotective therapy will be enrolled and followed prospectively. The study will assess patient-reported outcomes (PROs) related to gastrointestinal symptoms, as well as safety outcomes.
Official title: A Prospective, Multi-Center, Observational Study to Evaluate the Efficacy and Safety of Fexuclue Tablet 20 mg in Patients Requiring NSAIDs-Induced Peptic Ulcer Prevention
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
7000
Start Date
2026-04-30
Completion Date
2027-12-31
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Locations (1)
Multiple centers in Republic of Korea
Seoul, South Korea